Mazumdar Shaw's Mission to Expand Access to Vital Drugs
Share
Known as India's 'Queen of Biotech', Kiran Mazumdar-Shaw built Biocon from a rented garage almost 50 years ago. Today, her multibillion-dollar company is one of the world's biggest producers of insulin, and a leading force in biosimilars. As she looks at handing over her life's work to successors, Mazumdar-Shaw talks to Bloomberg's Haslinda Amin about her pioneering journey as a female entrepreneur in India, her mission to deliver life-saving therapies to patients and what she believes India must do to tackle an AI future.
More from Australia
Trans-Tasman insurers battle contract churn while defending profit margins
Capital battles heat up as takeover offers challenge listed housing operators
The equities fueling the next infrastructure supercycle
Crypto networks collide with sanctions in a fight for financial access
American Tungsten completes Nexus acquisition for Pinnacle MOU
Butn extends MYOB invoice financing agreement to 2027